Clinical Trials Directory

Trials / Completed

CompletedNCT05820737

A Study to Assess the Gut Health Effects of Heat-killed Post-biotics in Overweight and Obese Adults

A Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Assess the Gut Health Effects of Heat-killed Post-biotics EF2001 & beLP1 in Overweight and Obese Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
155 (actual)
Sponsor
Vedic Lifesciences Pvt. Ltd. · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The present study is a randomized, double-blind (Double dummy), placebo-controlled, parallel-group study to assess the gut health effects of heat-killed post biotics in overweight and obese individuals

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTEF2001One capsule to be consumed once a day
DIETARY_SUPPLEMENTbeLP1One capsule to be consumed once a day
DIETARY_SUPPLEMENTPlaceboOne capsule to be consumed once a day

Timeline

Start date
2024-04-14
Primary completion
2025-03-24
Completion
2025-03-24
First posted
2023-04-20
Last updated
2025-06-25

Locations

9 sites across 1 country: India

Source: ClinicalTrials.gov record NCT05820737. Inclusion in this directory is not an endorsement.

A Study to Assess the Gut Health Effects of Heat-killed Post-biotics in Overweight and Obese Adults (NCT05820737) · Clinical Trials Directory